Molecular Docking Studies of Nigella Sativa Linn Seed Compound Against Alzheimer's Disease: An in silico Study

PDF Review History

Published: 2024-03-22

Page: 32-42


S. Sudha

Department of Biotechnology, Srimad Andavan Arts and Science College (Autonomous), Affiliated to Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.

B. Chitra

Department of Biotechnology, Srimad Andavan Arts and Science College (Autonomous), Affiliated to Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.

S. Arif Nisha *

Regional Forensic Science Laboratory, Race Course Road, Kaja Nagar, Edamalaipatti Pudur, Tiruchirappalli, Tamil Nadu, India.

R. Beema Shafreen

Dr. Umayal Ramanathan College for Women, Affiliated to Alagappa University, Alagappapuram, Karaikudi, Tamil Nadu, India.

*Author to whom correspondence should be addressed.


Abstract

Alzheimer's disease is a neurological disorder that can lead to brain atrophy and dementia, affecting cognitive, social, behavioral, and emotional abilities. Medicinal plants have proven to be effective in addressing Alzheimer's disease. Nigella sativa Linn seeds have been extensively utilized in managing a range of nervous system conditions, including AD, epilepsy and neurotoxicity. In this study, it has been reported that the evaluation of the anti-Alzheimer potential of phytoconstituents in Nigella sativa Linn seeds was done using molecular docking analysis.            The AutoDock 4.2.6 software has used the chemical Kaempferol 3-(2-galloyl-alpha-L-arabinopyranoside) to identify and fulfill the Lamarckian genetic algorithm. The binding affinity of Kaempferol 3-(2-galloyl-alpha-L-arabinopyranoside) with key targets: acetylcholinesterase, amyloid beta peptide, and beta-secretase, represented by PDB IDs 7E3H, 2M4J, and 1FKN, respectively. Remarkably, Nigella sativa L., seeds exhibit a superior binding affinity and inhibitory effect on acetylcholinesterase (AChE), amyloid beta peptide (Aβ or APP) and beta-secretase (BACE) compared to conventional medication. Donepezil was employed as a positive control in this investigation. This study delves into the evaluation of Nigella sativa Linn's phytoconstituents for their potential in combating Alzheimer's disease through molecular docking analysis. Among the bioactive components of Nigella sativa Linn, kaempferol 3-(2-galloyl-alpha-L-arabinopyranoside) and the standard drug Donepezil stand out as promising candidates for therapeutic purposes. The affinity of Kaempferol 3-(2-galloyl-alpha-L-arabinopyranoside (Binding energy = -7.84 kcal/mol) to bind with acetylcholine esterase significantly surpasses that of the standard drug Donepezil, as indicated by the higher binding energy. The ligand efficiency of Kaempferol 3-(2-galloyl-alpha-L-arabinopyranoside, calculated as the binding energy per non-hydrogen atom (-0.37 kcal/mol), is also greater than that of the standard drug Donepezil. These findings underscore the importance of further comprehensive research on Kaempferol 3-(2-galloyl-alpha-L-arabinopyranoside) as a potential treatment for Alzheimer's disease, owing to its superior efficacy compared to existing medications.

Keywords: Kaempferol 3-(2"-galloyl-alpha-L-arabinopyranoside), donepezil, Alzheimer's disease, in silico, Nigella sativa Linn, Molecular docking


How to Cite

Sudha, S., Chitra, B., Nisha , S. A., & Shafreen, R. B. (2024). Molecular Docking Studies of Nigella Sativa Linn Seed Compound Against Alzheimer’s Disease: An in silico Study. Asian Journal of Advances in Medical Science, 6(1), 32–42. Retrieved from https://mbimph.com/index.php/AJOAIMS/article/view/3969

Downloads

Download data is not yet available.

References

Hameed S, Imran A, Nisa MU, Arshad MS, Saeed F, Arshad MU, Asif Khan M. Characterization of extracted phenolics from black cumin (Nigella sativa linn), coriander seed (Coriandrum sativum L.), and fenugreek seed (Trigonella foenum-graecum). International Journal of food properties. 2019;22(1):714-726.

DOI: 10.1080/10942912.2019.1599390.

Sutrisna E, Azizah T, Wahyuni S. Potency of Nigella sativa linn. Seed as antidiabetic (preclinical study). Research Journal of Pharmacy and Technology. 2022;15(1): 381-384.

DOI: 10.52711/0974-360X.2022.00062

Xiong J, Lipsitz O, Nasri F, Lui LM, Gill H, Phan L, Chen-Li D, Iacobucci M, Ho R, Majeed A. McIntyre RS. Impact of COVID-19 pandemic on mental health in the general population: A systematic review. Journal of affective disorders. 2020; 277:55-64 Available:https://doi.org/10.1016/j.jad.2020.08.001.

Thakur S, Kaurav H, Chaudhary G. Nigella sativa (Kalonji): A black seed of miracle. International Journal of Research and Review. 2021;8(4):342-357 Available:https://doi.org/10.52403/ijrr.20210441.

Begum S, Mannan A. A review on nigella sativa: a marvel herb. Journal of Drug Delivery and Therapeutics. 2020;10(2): 213-219. Available:https://doi.org/10.22270/jddt.v10i2.3913.

Basurra RS, Wang SM, Alhoot MA. Nigella sativa (Black Seed) as a natural remedy against viruses. J Pure Appl Microbiol. 2021;15(1):29-41. Available:https://doi.org/10.22207/JPAM.15.1.26

Knopman DS, Amieva H, Petersen RC, Chételat G, Holtzman DM, Hyman BT, Nixon RA, Jones DT. Alzheimer disease. Nature Reviews Disease Primers. 2021;7(1):33.

DOI: 10.1038/s41572-021-00269-y

Trang A, Khandhar PB. Physiology, acetylcholinesterase; 2019 Available:https://www.altmetric.com/details/112362369

Ahmad MF, Ahmad FA, Ashraf SA, Saad HH, Wahab S, Khan MI, Ali M, Mohan S, Hakeem KR. Athar MT. An updated knowledge of Black seed (Nigella sativa Linn.): Review of phytochemical constituents and pharmacological properties. Journal of herbal medicine. 2021;25:100404 Available:https://doi.org/10.1016/j.hermed.2020.100404

World Health Organization, Dementia fact sheet World Health Organization. Geneve, Switzerland: WHO Press; 2020.

Al-Snafi AE. Medicinal plants possessed beneficial therapeutic effects in Alzheimer’s disease and memory deficits. GSC Biological and Pharmaceutical Sciences. 2021;17(2):008-033 Available:https://doi.org/10.30574/gscbps.2021.17.2.0321.

Zhu D, Montagne A, Zhao Z. Alzheimer’s pathogenic mechanisms and underlying sex difference. Cellular and Molecular Life Sciences. 2021;78:4907-4920. DOI: 10.1007/s00018-021-03830-w

Majeed A, Muhammad Z, Ahmad H, Hayat SSS, Inayat N, Siyyar S. Nigella sativa L.: Uses in traditional and contemporary medicines–An overview. Acta Ecologica Sinica. 2021;41(4):253-258. Available:https://doi.org/10.1016/j.chnaes.2020.02.001

Zhu D, Montagne A, Zhao Z. Alzheimer's pathogenic mechanisms and underlying sex difference. Cell Mol Life Sci. 2021; 78(11):4907–4920. DOI: 10.1007/s00018-021-03830-w.

World Health Organization. Dementia Fact Sheet, Alzheimer’s Disease [Internet]. World Health Organisation; 2023.

Frisoni GB, Altomare D, Thal DR. The probabilistic model of Alzheimer disease: the amyloid hypothesis revised. Nat Rev Neurosci. 2022;23:53–66. Available:https://doi.org/10.1038/s41583-021-00533-w

Shafodino FS, Lusilao JM, Mwapagha LM. Phytochemical characterization and antimicrobial activity of Nigella sativa seeds. PloS One. 2022;17(8) Available:https://doi.org/10.1371/journal.pone.0272457

Teunissen CE, Verberk IM, Thijssen EH, Vermunt L, Hansson O, Zetterberg H, van der Flier, WM, Mielke MM, Del Campo M. Blood-based biomarkers for Alzheimer's disease: towards clinical implementation. The Lancet Neurology. 2022;21(1):66-77 Available:https://doi.org/10.1016/S1474-4422(21)00361-6

D’alessandro D, Gola M, Appolloni L, Dettori M, Fara GM, Rebecchi A, Settimo G, Capolongo, S. COVID-19 and living space challenge. Well-being and public health recommendations for a healthy, safe, and sustainable housing. Acta Bio Medica: Atenei Parmensis. 2020;91(9-S):61. DOI: 10.23750/abm.v91i9-S.10115

Yiannopoulou KG, Papageorgiou SG. Current and future treatments in Alzheimer disease: an update. Journal of Central Nervous System Disease. 2020;12: 1179573520907397 Available:https://doi.org/10.1177/1179573520907397

Yimer, Ebrahim M, Kald Beshir Tuem, Aman Karim, Najeeb Ur-Rehman, and Farooq Anwar. Nigella sativa L. (black cumin): a promising natural remedy for wide range of illnesses. Evidence-Based Complementary and Alternative Medicine; 2019 Available:https://doi.org/10.1155/2019/1528635.

Wang H, Kulas JA, Wang C, Holtzman DM, Ferris HA, Hansen SB. Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol. Proceedings of the National Academy of Sciences. 2021;118(33).

DOI:10.1073/pnas.2102191118//DCSupplemental.

Lott IT, Head E. Dementia in Down syndrome: unique insights for Alzheimer disease research. Nature Reviews Neurology. 2019;15(3):135-147. DOI: 10.1038/s41582-018-0132-6

Pardo-Moreno T, González-Acedo A, Rivas-Domínguez A, García-Morales V, García-Cozar FJ, Ramos-Rodríguez JJ, Melguizo-Rodríguez L. Therapeutic approach to Alzheimer’s disease: Current treatments and new perspectives. Pharmaceutics. 2022;14(6):1117 Available:https://doi.org/10.3390/harmaceutics14061117.

Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, Villemagne VL, Aisen P, Vendruscolo M, Iwatsubo T, Masters CL. The amyloid-β pathway in Alzheimer’s disease. Molecular Psychiatry. 2021;26 (10):5481-5503.

Available:https://doi.org/10.1038/s41380-021-01249-0.

Yadollahikhales G, Rojas JC. Anti-amyloid immunotherapies for Alzheimer's disease: a 2023 clinical update. Neurotherapeutics. 2023;20(4):914-931. Available:https://doi.org/10.1007/s13311-023-01405-0

Zhai K, Huang Z, Huang Q, Tao W, Fang X, Zhang A, Li X, Stark GR, Hamilton TA, Bao S, Pharmacological inhibition of BACE1 suppresses glioblastoma growth by stimulating macrophage phagocytosis of tumor cells. Nature Cancer. 2021;2(11): 1136-1151.

DOI: 10.1038/s43018-021-00267-9

Zhang H, Wei W, Zhao M, Ma L. Jiang X, Pei H, Cao Y, Li H. Interaction between Aβ and tau in the pathogenesis of Alzheimer's disease. International Journal of Biological Sciences. 2021;17(9):2181.

DOI: 10.7150/ijbs.57078

Kent SA, Spires-Jones TL, Durrant CS. The physiological roles of tau and Aβ: implications for Alzheimer’s disease pathology and therapeutics. Acta neuropathologica. 2020;140(4):417-447. Available:https://doi.org/10.1007/s00401-020-02196-w

Panza F, Lozupone M, Seripa D, Imbimbo BP. Amyloid‐β immunotherapy for alzheimer disease: Is it now a long shot?. Annals of Neurology. 2019;85(3): 303-315.

DOI: 10.1002/ana.25410.

Busche MA, Hyman BT., Synergy between amyloid-β and tau in Alzheimer’s disease. Nature Neuroscience. 2020;23(10):1183-1193. Available:m.busche@ucl.ac.uk.

Imbimbo BP, Watling M. Investigational BACE inhibitors for the treatment of Alzheimer’s disease. Expert Opinion on Investigational Drugs. 2019;28(11):967-975. Available:https://www.tandfonline.com/loi/ieid20

Maia MA, Sousa E. BACE-1 and γ-secretase as therapeutic targets for Alzheimer’s disease. Pharmaceuticals. 2019;12(1):41. Available:https://doi.org/10.3390/ph12010041.

Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179(2): 312-339. Available:https://doi.org/10.1016/j.cell.2019.09.001

Vaz M, Silvestre S. Alzheimer's disease: Recent treatment strategies. European Journal of Pharmacology. 2020;887: 173554.Available:https://doi.org/10.1016/j.ejphar.2020.173554.

Sudha S, Chitra B, Arif Nisha S, Evaluation of neuroprotective effect and identification of active compounds from Nigella sativa Linn. through bioactive guided fractionation. Res. J. Biotech. 2024;19(3); 39-47; DOI:https://doi.org/10.25303/1903rjbt039047

Ravelliani A, Sari LK, Marisah M, Agustin AE, Maharani D, Utami MR, Nurfadhila L. Study of molecular docking on compounds with potential as anti-inflammatory. Journal Eduhealth. 2022;13 (02):1070-1078. Available:http://ejournal.seaninstitute.or.id/index.php/healt.

Kartsev V, Geronikaki A, Zubenko A, Petrou A, Ivanov M, Glamočlija J, Sokovic M, Divaeva L, Morkovnik A, Klimenko A. Synthesis and antimicrobial activity of new heteroaryl (aryl) thiazole derivatives molecular docking studies. Antibiotics. 2022;11(10):1337 Available:https://doi.org/10.3390/ antibiotics11101337.

Cetin A. Molecular Docking and Pharmacokinetic Studies of Aquillochin and Grewin as SARS-CoV-2 Mpro Inhibitors. Drug Delivery Letters. 2022;12(1):54- 61 Available:https://doi.org/10.2174/2210303112666220318151336

Sinlapapanya P, Sumpavapol P, Nirmal N, Zhang B, Hong H, Benjakul S. Ethanolic cashew leaf extract: Antimicrobial activity, mode of action, and retardation of spoilage bacteria in refrigerated Nile tilapia slices. Foods. 2022;11(21):3461. Available:https://doi.org/ 10.3390/foods11213461

Satpute UM, Rohane SH. Efficiency of AUTODOCK: insilico study of pharmaceutical drug molecules; 2021 DOI :10.5958/0974-4150.2021.00016.X.

Supandi S, Wulandari MS, Samsul E, Azminah A, Purwoko RY, Herman H, Kuncoro H, Ibrahim A, Ambarwati NSS, Rosmalena R, Azizah RN. Dipeptidyl peptidase IV inhibition of phytocompounds from Artocarpus champeden (Lour.) Stokes: In silico: molecular docking study and ADME-Tox prediction approach. Journal of Advanced Pharmaceutical Technology & Research. 2022;13(3):207-215.

DOI: 10.4103/japtr.japtr_376_22

Olatunde OO, Della Tan SL, Shiekh KA, Benjakul S, Nirmal NP. Ethanolic guava leaf extracts with different chlorophyll removal processes: Anti-melanosis, antibacterial properties and the impact on qualities of Pacific white shrimp during refrigerated storage. Food Chemistry. 2021;341:12825 Available:https://doi.org/10.1016/j.foodchem.2020.128251.

Yuan Y, Zhong S, Deng Z, Li G, Li H. Impact of particle size on the nutrition release and antioxidant activity of rape, buckwheat and rose bee pollens. Food & Function. 2023;14(4): 1897-1908 DOI: https://doi.org/10.1039/D2FO03119A.